ArticleBioMed research international2022

Novel Target Study to Cure Cardiovascular Disease regarding Proprotein Converse Subtilisin/Kexin Type 9.

Yingjing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.